Behçet Disease
📧 Sign up to get email alerts when something new happens for Behçet Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-02-27Clinical Trial Update: Baricitinib in the Treatment of Intestinal Behçet's Syndrome [Phase 2]
A Phase 2 clinical trial evaluating baricitinib for intestinal Behçet's disease is currently recruiting.
-
CLINICAL_TRIALS research · 2025-02-20Clinical Trial Update: Evaluation of Voice in Behcet's
A clinical trial sponsored by Minia University evaluating voice in Behçet's disease is listed as NOT_YET_RECRUITING.
-
CLINICAL_TRIALS trial_result · 2025-02-05Clinical Trial Update: Pilates Based Exercises in Patients With Behçet and Familial Mediterranean Fever. [NA]
A completed clinical trial evaluating Pilates-based exercises in patients with Behçet's disease and familial Mediterranean fever.
-
CLINICAL_TRIALS research · 2025-02-04Clinical Trial Update: Familial Mediterranean Fever and Behçet: Analysis Before and After Covid19 Pandemic
A completed clinical-trial analysis examining Familial Mediterranean Fever and Behçet disease before and after the COVID-19 pandemic.
-
CLINICAL_TRIALS research · 2025-01-09Clinical Trial Update: A Registry Study Assessing PRO, Dosing Patterns, and Safety of Vunakizumab in Patients With General Rheumatic Diseases.
Registry study evaluating patient-reported outcomes, dosing patterns, and safety of Vunakizumab in several rheumatic diseases; recruitment h…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2024-12-17Clinical Trial Update: Pan-immune-inflammation Value (PIN) in Behçet's Disease and Its Correlation With Disease Activity
A clinical trial evaluating pan-immune-inflammation value (PIN) as a biomarker for disease activity in Behçet's disease, examining its corre…
-
CLINICAL_TRIALS research · 2024-12-10Clinical Trial Update: Role of Femoral Vein Wall Thickness and Inflammatory Markers in Patients With Behcet Disease
A clinical trial evaluating femoral vein wall thickness and inflammatory markers in Behçet disease is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: Understanding the Role of Oral Microbiota in Behçet's Disease (BEHCETBIOT)
A completed clinical trial investigating the role of oral microbiota in the physiopathology of Behçet disease.
-
CLINICAL_TRIALS trial_result · 2024-08-15Clinical Trial Update: Association of Auditory Dysfunction With Retinal Ischemia in Behcet Disease
A completed clinical trial examines the relationship between auditory dysfunction and retinal ischemia in Behçet's disease.
-
CLINICAL_TRIALS research · 2024-06-26Clinical Trial Update: Drug Rediscovery for Rare Immune Mediated Inflammatory Diseases [Phase 2]
A Phase 2 clinical trial update for rediscovering a drug for rare immune-mediated inflammatory diseases, with recruitment ongoing for Behçet…
-
CLINICAL_TRIALS research · 2024-06-11Clinical Trial Update: Thrombophilia and Thrombosis in Behçet's Disease
This clinical trial is recruiting to investigate thrombophilia and thrombosis in Behçet disease.
-
FDA approval · 2024-04-25FDA Approved: OTEZLA — Supplemental Application (Amgen, Inc)
The FDA approved Amgen's supplemental application for OTEZLA (apremilast), resulting in an approved supplemental change to the product label…
-
CLINICAL_TRIALS research · 2024-04-25Clinical Trial Update: Intestinal Ultrasound, Magnetic Resonance Enterography, and Conventional Assessment Tools Before and After Treatment of Intestinal Behcet's Disease
This Yonsei University clinical trial evaluates intestinal imaging (ultrasound and MR enterography) alongside conventional assessment tools …
-
CLINICAL_TRIALS trial_result · 2023-07-03Clinical Trial Update: Induction Therapy With Anti-TNFα vs Cyclophosphamide in Severe Behçet Disease [Phase 3]
A Phase 3 clinical trial comparing induction therapy with anti-TNFα versus cyclophosphamide in severe Behçet's disease has completed.
-
CLINICAL_TRIALS trial_result · 2021-07-20Clinical Trial Update: Induction of Regulatory t Cells by Low Dose il2 in Autoimmune and Inflammatory Diseases [Phase 2]
Phase 2 clinical trial evaluating low-dose IL-2 to induce regulatory T cells in various autoimmune and inflammatory diseases; trial complete…
-
CLINICAL_TRIALS trial_result · 2021-02-23Clinical Trial Update: Interferon α2a Versus Cyclosporine for Refractory Behçet's Disease Uveitis [Phase 3]
A Phase 3 trial comparing Interferon α2a to Cyclosporine for refractory Behçet's disease uveitis has completed.
-
CLINICAL_TRIALS trial_result · 2020-06-11Clinical Trial Update: 1 Year of Treatment With Canakinumab in Behçet's Disease Patients With Neurologic or Vascular Involvement [Phase 2]
Phase 2 trial update reporting 1 year of.canakinumab treatment in Behçet's disease patients with neurologic or vascular involvement; study c…
-
CLINICAL_TRIALS trial_result · 2020-01-03Clinical Trial Update: Efficacy of Gevokizumab in the Treatment of Patients With Behçet's Disease Uveitis (EYEGUARD™-B) [Phase 3]
Phase 3 trial EYEGUARD-B evaluating gevokizumab for Behçet's disease-related uveitis has been terminated.
-
FDA approval · 2019-09-16FDA Approved: COLCHICINE — Original Application (Mylan Pharmaceuticals Inc.)
The FDA approved a generic colchicine product from Mylan Pharmaceuticals Inc. under an original ANDA (ANDA209470).
-
CLINICAL_TRIALS trial_result · 2019-09-11Clinical Trial Update: A Phase 3 Randomized, Double-blind Study to Evaluate the Efficacy and Safety of Apremilast (CC-10004) in Subjects With Active Behçet's Disease [Phase 3]
Phase 3 randomized trial evaluating Apremilast for active Behçet's disease has completed with results posted.
-
CLINICAL_TRIALS research · 2019-02-15Clinical Trial Update: Inactivity Behavior and Exercise Bariers in Patients With Behçet Disease [NA]
A clinical trial update examining inactivity behavior and barriers to exercise in patients with Behçet disease.
-
FDA approval · 2019-02-08FDA Approved: COLCHICINE — Original Application (Ascend Laboratories, LLC)
FDA approved Ascend Laboratories, LLC's original ANDA application for Colchicine, making a generic colchicine product available in the U.S.
-
CLINICAL_TRIALS trial_result · 2019-02-06Clinical Trial Update: Evaluation of Fibromyalgia With Disease Activity and Clinical Findings in Women With Behçet's Disease
This clinical trial update notes the completion of a study evaluating fibromyalgia symptoms in women with Behçet's disease.
-
CLINICAL_TRIALS trial_result · 2019-01-28Clinical Trial Update: A Pilot Study of the Safety and Efficacy of Abatacept Injections in the Treatment of Behcet's Syndrome [EARLY_Phase 1]
An early-phase pilot study evaluated the safety and potential efficacy of abatacept injections for Behçet's disease; the trial has completed…
-
FDA approval · 2018-11-29FDA Approved: COLCHICINE — Original Application (Par Health USA, LLC)
The FDA approved an original ANDA for colchicine from Par Health USA, LLC, enabling the marketing of a generic colchicine product. This repr…